Navigation Links
Miraca Life Sciences Announces Significant American College of Gastroenterology Tradeshow Plans
Date:9/18/2013

IRVING, Texas (PRWEB) September 18, 2013

Miraca Life Sciences, the leading pathology services provider that collaborates to make patients and practices better, today announced that it will have a significant presence at the American College of Gastroenterology (ACG tradeshow), the annual scientific meeting for GI professionals October 11 – 16th in San Diego, CA.

In addition to participating in the Exhibitor Hall, Miraca will be offering an informative presentation on Meaningful Use compliance for the first 100 participants in the Exhibitor Theater on Tuesday, October 15th at 1:40 pm. At this presentation, Miraca will help GI physicians advance their workflow efficiency toward full EHR integration and offer guidance on forthcoming regulatory concerns to successfully attest to Meaningful Use requirements.

Visitors to Miraca Life Sciences’ booth, # 1015, can learn how to leverage MMR IHC testing to identify patients at risk for having Lynch Syndrome. Hereditary nonpolyposis colon cancer (HNPCC), also known as Lynch syndrome, is an inherited cancer that predisposes patients to the development of colorectal, endometrial, gastric, upper urinary tract, and other cancers. Visitors to booth # 1015 can learn how to evaluate tumors for the characteristics common to individuals with HNPCC/Lynch syndrome which include microsatellite instability and loss of protein expression of one or more of the genes associated with HNPCC/Lynch syndrome.

"Miraca has a responsibility to doctors and patients to deliver reliable, meaningful laboratory results because effective patient care stems from accurate interpretation and diagnosis, so we'll be introducing a number of exciting innovations," said Dr. Amy Noffsinger, Medical Director for Miraca Life Sciences.

In addition, seven abstracts submitted by Miraca Life Sciences’ pathologists to the American College of Gastroenterology were accepted for posters. The posters that will be presented at ACG by Miraca Life Sciences this year include:

  • Eosinophilic Esophagitis is Associated with an Increased Prevalence of Inflammatory Bowel Disease
  • Intestinal Spirochetosis is Associated with Diarrhea, Weight Loss, and Abdominal Pain in Less Than Half of the Infected Subjects: A Study of 447 Patients and 1.2 Million Controls
  • Esophageal Eosinophilia and Gastric Mucosal Pathology: Is There a Link?
  • Unexpected Candidiasis in the Endoscopically Normal Esophagus
  • Helicobacter negative Chronic Active Gastritis is a Distinct Nosologic Entity, Not Simply Missed Helicobacter Infection
  • Low Prevalence of Colon Polyps in Patients with Diarrhea and Microscopic Colitis
  • Gastric Pathology in HIV-Infected Patients

"Miraca understands every biopsy represents a patient apprehensively awaiting an answer, and Miraca believes every patient deserves the right answer. The right answer is more than a diagnosis; it is specific, accurate, sophisticated, and actionable medical information derived from collaboration by the best subspecialist pathologists," said Dr. Noffsinger. "Our 'customer first' approach is the real driver behind our innovation, and we're very excited about the many opportunities we have to showcase our new solutions in 2013."

About Miraca Life Sciences

Miraca Life Sciences specializes in the development and commercialization of the highest quality academic pathology services, primarily in the fields of dermatology, hematology, gastroenterology and urology. The company’s core team of more than 70 academic-caliber specialists utilize state-of-the-art pathology laboratories currently headquartered in Irving, Texas, and throughout the United States to serve more than 3,500 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.

About Miraca Holdings

With group net sales of ¥192.2 billion (FYE 3/2013), Miraca Holdings, a Japan-based holding company in the healthcare sector, is engaged in the business consisting of three segments: (i) development, manufacture, and commercialization of in vitro diagnostics, (ii) clinical laboratory testing, and (iii) other healthcare related businesses, which are conducted by its subsidiaries and affiliates including Fujirebio Inc,. a leading supplier of in vitro diagnostics in Japan, and SRL, Inc., Japan’s largest commercial laboratory testing services to medical institutes throughout the nation, ranging from general testing to esoteric testing, including gene-based tests.

About ACG

The American College of Gastroenterology is a recognized leader in educating GI professionals and the general public about digestive disorders. Our mission: to serve the evolving needs of physicians in the delivery of high quality scientific, humanistic and cost-effective health care to gastroenterology patients.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11092334.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Life Sciences Discovery Fund announces $3.7m in research and development grants
2. UAS LifeSciences Launches New Brand at Expo East
3. New Name, Same Commitment to Advancing the Neurological Sciences: The Movement Disorder Society (MDS) Becomes the International Parkinson and Movement Disorder Society
4. Western University of Health Sciences to Welcome More Than 1,100 New Students
5. AxoGen, Inc. to Present at the Wedbush 2013 Life Sciences Management Access Conference
6. Patheon’s Michael Lehmann Named Among PharmaVOICE 100 List of Most Inspiring People in Life Sciences Industry
7. Scott Sheldon – Specialist in Healthcare and Life Sciences Supply Chain & Official Sponsor of LogiPharma 2013
8. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement
9. CMUs Kathryn Roeder to receive Outstanding Achievement by a Woman in Statistical Sciences award
10. AKA Enterprise Solutions Launches CRM and ERP Web Site for Life Sciences
11. Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology: